δ-Opioid Receptor and Somatostatin Receptor-4 Heterodimerization: Possible Implications in Modulation of Pain Associated Signaling-Reference-Cited by-同舟云学术

δ-Opioid Receptor and Somatostatin Receptor-4 Heterodimerization: Possible Implications in Modulation of Pain Associated Signaling

Published:2014-01-08 Issue:1 Volume:9 Page:e85193
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Somvanshi Rishi K.,Kumar Ujendra

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference71 articles.

1. Opioids and their complicated receptor complexes;BA Jordan;Neuropsychopharmacology,2000

2. Opioids: first lessons from knockout mice;BL Kieffer;Trends Pharmacol Sci,1999

3. Role of delta-opioid receptors in biological processes;A Coop;Drug News Perspect,2000

4. Opioid receptor genes inactivated in mice: the highlights;C Gaveriaux-Ruff;Neuropeptides,2002

5. Differential effects of intrathecally administered delta and mu opioid receptor agonists on formalin-evoked nociception and on the expression of Fos-like immunoreactivity in the spinal cord of the rat;DL Hammond;J Pharmacol Exp Ther,1998

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring key features of selectivity in somatostatin receptors through molecular dynamics simulations;Computational and Structural Biotechnology Journal;2024-12

2. J-2156, a small molecule somatostatin type 4 receptor agonist, alleviated hindpaw hypersensitivity in the streptozotocin-induced rat model of painful diabetic neuropathy but with a 2-fold decrease in potency at an advanced stage in the model, mimicking morphine;Frontiers in Pharmacology;2024-01-22

3. Comparative changes in breast cancer cell proliferation and signalling following somatostatin and cannabidiol treatment;Biochemical and Biophysical Research Communications;2023-02

4. Les hétéromères impliquant le récepteur opioïde δ : des cibles potentielles pour soulager la douleur chronique ?;Douleur et Analgésie;2022-09

5. Therapeutic potential of opioid receptor heteromers in chronic pain and associated comorbidities;British Journal of Pharmacology;2022-01-21